Received May 12, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 343DD | — |
Expired dose administered/gave a Menveo vaccine that was expired to a patient. dose had expired on 30-Apr-2026; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 343DD, expiry date 30-APR-2026) for prophylaxis. On 04-MAY-2026, the patient received Menveo. On 04-MAY-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Expired dose administered/gave a Menveo vaccine that was expired to a patient. dose had expired on 30-Apr-2026). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 04-MAY-2026 The patient had been administered an expired dose of the Menveo vaccine. It was a one-vial presentation of Menveo.